TTOO RSI Chart
Last 7 days
53.7%
Last 30 days
92.9%
Last 90 days
4.0%
Trailing 12 Months
1967.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 7.2M | 0 | 0 | 0 |
2023 | 17.1M | 13.2M | 11.0M | 7.2M |
2022 | 28.3M | 27.6M | 23.8M | 22.3M |
2021 | 22.5M | 26.7M | 28.9M | 28.1M |
2020 | 9.1M | 9.8M | 13.4M | 18.1M |
2019 | 10.0M | 7.8M | 7.1M | 8.3M |
2018 | 6.0M | 9.0M | 10.4M | 10.5M |
2017 | 3.9M | 3.9M | 3.9M | 4.7M |
2016 | 3.7M | 4.1M | 4.2M | 4.1M |
2015 | 454.0K | 927.0K | 1.9M | 2.8M |
2014 | 0 | 0 | 0 | 385.0K |
2013 | 0 | 101.3K | 183.7K | 266.0K |
2012 | 0 | 0 | 0 | 19.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 03, 2024 | cr group l.p. | acquired | - | - | 403,608 | - |
May 03, 2024 | cr group l.p. | acquired | - | - | 1,565,440 | - |
May 03, 2024 | cr group l.p. | acquired | - | - | 129,629 | - |
May 03, 2024 | cr group l.p. | acquired | - | - | 2,001,510 | - |
May 03, 2024 | cr group l.p. | acquired | - | - | 648,139 | - |
Apr 12, 2024 | cr group l.p. | acquired | - | - | 682,036 | - |
Apr 12, 2024 | cr group l.p. | acquired | - | - | 424,716 | - |
Apr 12, 2024 | cr group l.p. | acquired | - | - | 390,142 | - |
Apr 12, 2024 | cr group l.p. | acquired | - | - | 1,647,320 | - |
Apr 12, 2024 | cr group l.p. | acquired | - | - | 136,409 | - |
Which funds bought or sold TTOO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -96,741 | - | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -88.33 | -711 | 42.00 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | unchanged | - | -7.00 | 6.00 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 40.17 | -4,221 | 8,574 | -% |
May 15, 2024 | Royal Bank of Canada | added | 6.3 | -4,000 | 4,000 | -% |
May 13, 2024 | UBS Group AG | new | - | 5,250 | 5,250 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 15.74 | -67,435 | 83,538 | -% |
May 10, 2024 | GROUP ONE TRADING, L.P. | reduced | -37.7 | -14,469 | 6,138 | -% |
May 10, 2024 | VANGUARD GROUP INC | unchanged | - | -149,651 | 137,085 | -% |
May 10, 2024 | BlackRock Inc. | unchanged | - | -121,047 | 110,883 | -% |
Unveiling T2 Biosystems Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to T2 Biosystems Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 196.9B | 23.7B | 44.73 | 8.29 | ||||
A | 45.2B | 6.7B | 36.57 | 6.71 | ||||
IDXX | 44.9B | 3.7B | 51.83 | 12.06 | ||||
DGX | 16.0B | 9.3B | 18.95 | 1.73 | ||||
NTRA | 13.1B | 1.2B | -35.76 | 10.81 | ||||
MEDP | 12.2B | 2.0B | 38.94 | 6.2 | ||||
CRL | 11.4B | 4.1B | 26.02 | 2.78 | ||||
EXAS | 9.3B | 2.5B | -38.69 | 3.67 | ||||
MID-CAP | ||||||||
GH | 3.1B | 603.7M | -6.73 | 5.14 | ||||
NEOG | 2.9B | 929.2M | 1.9K | 3.16 | ||||
SMALL-CAP | ||||||||
CDNA | 808.3M | 275.1M | -4.41 | 2.94 | ||||
ACRS | 84.8M | 31.1M | -1.1 | 2.73 | ||||
AWH | 33.0M | 9.2M | -2.24 | 3.6 | ||||
APDN | 2.5M | 5.5M | -0.2 | 0.45 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
T2 Biosystems Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 22.8% | 2,061 | 1,679 | 1,472 | 1,964 | 2,078 | 5,483 | 3,677 | 5,911 | 7,234 | 6,980 | 7,428 | 6,694 | 6,956 | 7,788 | 5,245 | 2,552 | 2,545 | 3,069 | 1,677 | 1,804 | 1,785 |
Costs and Expenses | 33.3% | 14,661 | 10,998 | 15,079 | 15,015 | 15,765 | 15,003 | 19,477 | 20,930 | 22,091 | 17,259 | 19,640 | 17,474 | 16,658 | 16,108 | 15,881 | 11,391 | 16,106 | 15,436 | 14,023 | 15,590 | 15,344 |
S&GA Expenses | 28.2% | 6,738 | 5,255 | 5,980 | 6,296 | 7,299 | 6,554 | 7,017 | 7,824 | 9,230 | 6,544 | 8,536 | 7,244 | 6,203 | 4,868 | 5,266 | 5,305 | 6,655 | 7,546 | 5,981 | 6,722 | 7,055 |
R&D Expenses | 17.4% | 3,721 | 3,169 | 2,663 | 3,850 | 4,471 | 4,659 | 6,375 | 8,025 | 6,656 | 5,353 | 6,384 | 5,399 | 4,665 | 3,764 | 3,782 | 3,786 | 4,780 | 4,279 | 4,098 | 4,048 | 3,901 |
Interest Expenses | 360.6% | 839 | -322 | 1,119 | 1,541 | 1,522 | -639 | 1,560 | 1,346 | 1,650 | 2,369 | 1,919 | 1,881 | 1,013 | 1,610 | 647 | 1,844 | 1,417 | 3,914 | 1,168 | 1,136 | 1,131 |
Net Income | -30.9% | -13,534 | -10,340 | -15,425 | -6,347 | -17,965 | -10,099 | -17,375 | -18,034 | -16,495 | -12,144 | -13,962 | -12,475 | -10,660 | -9,909 | -11,255 | -10,685 | -14,949 | -14,041 | -14,171 | -15,647 | -15,147 |
Net Income Margin | 8.6% | -6.36* | -6.96* | -4.53* | -3.92* | -3.70* | -2.78* | -2.69* | -2.20* | -1.94* | -1.75* | -1.63* | -1.66* | -1.89* | -2.58* | - | - | - | - | - | - | - |
Free Cashflow | -24.0% | -11,709 | -9,442 | -13,406 | -12,420 | -13,060 | -10,365 | -16,029 | -10,104 | -14,470 | -10,041 | -9,685 | -10,703 | -8,905 | -9,129 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -28.9% | 25.00 | 35.00 | 43.00 | 37.00 | 33.00 | 34.00 | 44.00 | 40.00 | 49.00 | 61.00 | 70.00 | 79.00 | 70.00 | 79.00 | 78.00 | 54.00 | 51.00 | 28.00 | 34.00 | 45.00 | 56.00 |
Current Assets | -38.2% | 16.00 | 25.00 | 33.00 | 24.00 | 19.00 | 19.00 | 29.00 | 25.00 | 34.00 | 44.00 | 54.00 | 64.00 | 45.00 | 54.00 | 51.00 | 47.00 | 44.00 | 19.00 | 24.00 | 33.00 | 44.00 |
Cash Equivalents | -56.7% | 7.00 | 16.00 | 24.00 | 16.00 | 10.00 | 10.00 | 20.00 | 13.00 | 9.00 | 22.00 | 22.00 | 33.00 | 11.00 | 17.00 | 19.00 | 27.00 | 36.00 | 11.00 | 16.00 | 28.00 | 37.00 |
Inventory | -3.1% | 5.00 | 5.00 | 4.00 | 4.00 | 5.00 | 4.00 | 4.00 | 6.00 | 5.00 | 4.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 |
Net PPE | -2.8% | 2.00 | 2.00 | 2.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 6.00 | 6.00 | 7.00 | 7.00 |
Liabilities | -0.5% | 63.00 | 63.00 | 63.00 | 74.00 | 83.00 | 74.00 | - | - | - | 73.00 | - | - | - | - | - | - | - | - | - | - | - |
Current Liabilities | 0.2% | 56.00 | 56.00 | 55.00 | 66.00 | 18.00 | 10.00 | 11.00 | 13.00 | 13.00 | 12.00 | 11.00 | 9.00 | 10.00 | 10.00 | 10.00 | 8.00 | 58.00 | 61.00 | 58.00 | 58.00 | 54.00 |
Shareholder's Equity | -34.8% | -37.80 | -28.04 | - | - | -49.89 | -39.65 | - | - | - | -12.90 | - | 9.00 | - | 9.00 | 18.00 | - | - | - | - | - | - |
Retained Earnings | -2.3% | -597 | -584 | -574 | -558 | -552 | -534 | -524 | -506 | -488 | -472 | -460 | -446 | -433 | -422 | -413 | -401 | -391 | -376 | -362 | -347 | -332 |
Additional Paid-In Capital | 0.7% | 560 | 556 | 555 | 522 | 502 | 495 | 492 | 469 | 463 | 459 | 457 | 455 | 433 | 432 | 431 | 397 | 383 | 342 | 336 | 332 | 331 |
Shares Outstanding | 35.8% | 6.00 | 4.00 | 4.00 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 17.00 | - | - | - | 31.00 | - | - | - | 189 | - | - | - | 148 | - | - | - | 64.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -24.1% | -11,683 | -9,416 | -13,393 | -12,387 | -12,940 | -10,329 | -15,903 | -9,956 | -14,441 | -9,842 | -9,727 | -10,597 | -8,708 | -8,750 | -6,234 | -13,491 | -14,740 | -10,119 | -13,535 | -8,840 | -12,867 |
Share Based Compensation | 119.1% | 1,595 | 728 | 877 | 913 | 1,833 | 1,035 | 1,372 | 1,534 | 2,552 | 1,473 | 2,466 | 1,843 | 1,308 | 904 | 855 | 994 | 1,160 | 983 | 1,165 | 1,277 | 2,033 |
Cashflow From Investing | 100.0% | - | -26.00 | -13.00 | -33.00 | -120 | -36.00 | -126 | 9,850 | -29.00 | 9,801 | 42.00 | 12,395 | 2,553 | 6,372 | -33,263 | -9,303 | -67.00 | -26.00 | -291 | -250 | -194 |
Cashflow From Financing | 171.2% | 2,202 | 812 | 21,641 | 18,387 | 11,848 | 748 | 23,183 | 3,921 | 1,202 | 239 | 24.00 | 20,219 | 53.00 | 112 | 32,398 | 13,000 | 40,097 | 4,965 | 1,617 | 112 | -344 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Total revenue | $ 2,061 | $ 2,078 |
Costs and expenses: | ||
Research and development | 3,721 | 4,471 |
Selling, general and administrative | 6,738 | 7,299 |
Total costs and expenses | 14,661 | 15,765 |
Loss from operations | (12,600) | (13,687) |
Other income (expense): | ||
Interest expense to related party | (1,179) | (1,522) |
Change in fair value of derivative related to Term Loan with related party | (108) | (770) |
Change in fair value of warrant liabilities | 28 | (1,304) |
Other, net | 325 | (682) |
Total other income (expense) | (934) | (4,278) |
Net loss | $ (13,534) | $ (17,965) |
Net loss per share - basic | $ (2.66) | $ (131.77) |
Net loss per share - diluted | $ (2.66) | $ (131.77) |
Weighted-average number of common shares used in computing net loss per share - basic | 5,094,809 | 136,333 |
Weighted-average number of common shares used in computing net loss per share - diluted | 5,094,809 | 136,333 |
Other comprehensive loss: | ||
Net loss | $ (13,534) | $ (17,965) |
Comprehensive loss | (13,534) | (17,965) |
Product [Member] | ||
Revenue: | ||
Total revenue | 2,061 | 1,655 |
Costs and expenses: | ||
Cost of product revenue | $ 4,202 | 3,995 |
Contribution [Member] | ||
Revenue: | ||
Total revenue | $ 423 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 6,208 | $ 15,689 |
Accounts receivable, net | 1,588 | 1,420 |
Inventories | 4,670 | 4,819 |
Prepaid expenses and other current assets | 3,094 | 3,261 |
Total current assets | 15,560 | 25,189 |
Property and equipment, net | 1,611 | 1,658 |
Operating lease right-of-use assets | 7,031 | 7,395 |
Restricted cash | 551 | 551 |
Other assets | 2 | 4 |
Total assets | 24,755 | 34,797 |
Current liabilities: | ||
Accounts payable | 1,887 | 1,527 |
Accrued expenses and other current liabilities | 4,231 | 4,905 |
Operating lease liability | 1,651 | 1,616 |
Warrant liabilities | 207 | 235 |
Deferred revenue | 185 | 224 |
Total current liabilities | 56,256 | 56,152 |
Operating lease liabilities, net of current portion | 6,180 | 6,598 |
Deferred revenue, net of current portion | 92 | 83 |
Total liabilities | 62,528 | 62,833 |
Commitments and contingencies (see Note 14) | ||
Stockholders’ deficit | ||
Preferred stock, $0.001 par value; 10,000,000 shares authorized: Series B Convertible Preferred Stock, 10,875 shares designated on March 31, 2024,10,875 and 93,297 shares issued and outstanding to related party on March 31, 2024 and December 31, 2023, respectively | ||
Common stock, $0.001 par value; 400,000,000 shares authorized; 5,512,332 and 4,058,381 shares issued and outstanding on March 31,2024 and December 31, 2023, respectively | 6 | 4 |
Additional paid-in capital | 560,051 | 556,256 |
Accumulated deficit | (597,830) | (584,296) |
Total stockholders’ deficit | (37,773) | (28,036) |
Total liabilities and stockholders' deficit | 24,755 | 34,797 |
Related Party [Member] | ||
Current liabilities: | ||
Notes payable | 41,666 | 41,284 |
Accrued final payment fee on Term Loan | 4,767 | 4,807 |
Derivative liability related to Term Loan | $ 1,662 | $ 1,554 |